Demand for Hepatitis E Diagnostic Tests in USA

Demand for Hepatitis E Diagnostic Tests in USA Size and Share Forecast Outlook 2025 to 2035

Demand for hepatitis E diagnostic tests in USA is projected to grow from USD 14.20 million in 2025 to USD 21.80 million by 2035, registering 4.8% CAGR. By test type, the ELISA HEV IgM tests segment registers 48.3% share. Based on end use, the hospitals segment holds 41.2% share.

Demand for Hepatitis E Diagnostic Tests in USA
  • FACT12525MR
  • 11 Dec 2025
  • Healthcare
  • 170 Pages
  • 6 Tables
  • 21 Figures

Table of Content

  1. Executive Summary
    • USA Market Outlook
    • Demand to side Trends
    • Supply to side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
  2. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  3. Market Background
    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunity
      • Trends
    • Scenario Forecast
      • Demand in Optimistic Scenario
      • Demand in Likely Scenario
      • Demand in Conservative Scenario
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter’s Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. USA Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
    • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
      • YoY Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. USA Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
  6. USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Test Type
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Test Type, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Test Type, 2025 to 2035
      • ELISA HEV IgM Tests
      • ELISA HEV IgG Tests
      • Rapid Diagnostic Tests
      • PCR Tests
      • Others
    • Y to o to Y Growth Trend Analysis By Test Type, 2020 to 2024
    • Absolute $ Opportunity Analysis By Test Type, 2025 to 2035
  7. USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End Use
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By End Use, 2020 to 2024
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By End Use, 2025 to 2035
      • Hospitals
      • Diagnostic Laboratories
      • Blood Banks
      • Others
    • YoY Growth Trend Analysis By End Use, 2020 to 2024
    • Absolute $ Opportunity Analysis By End Use, 2025 to 2035
  8. USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
      • USA
    • Market Attractiveness Analysis By Region
  9. USA Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
      • By Country
      • By End Use
      • By Test Type
    • Market Attractiveness Analysis
      • By Country
      • By End Use
      • By Test Type
    • Key Takeaways
  10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By End Use
      • By Test Type
  11. Competition Analysis
    • Competition Deep Dive
      • F. Hoffmann-La Roche Limited
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
        • Wantai BioPharm
        • PerkinElmer Incorporated
        • Altona Diagnostics
        • MP Biomedicals LLP
        • Dia.Pro Diagnostic Bioprobes srl
        • ELITechGroup
        • Primerdesign Limited
        • Mikrogen GmbH
        • Fortress Diagnostics
  12. Assumptions & Acronyms Used
  13. Research Methodology

List Of Table

  • Table 1: USA Market Value (USD Million) Forecast by Region, 2020 to 2035
  • Table 2: USA Market Value (USD Million) Forecast by Test Type, 2020 to 2035
  • Table 3: USA Market Value (USD Million) Forecast by End Use, 2020 to 2035
  • Table 4: USA Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 5: USA Market Value (USD Million) Forecast by Test Type, 2020 to 2035
  • Table 6: USA Market Value (USD Million) Forecast by End Use, 2020 to 2035

List Of Figures

  • Figure 1: USA Market Pricing Analysis
  • Figure 2: USA Market Value (USD Million) Forecast 2020 to 2035
  • Figure 3: USA Market Value Share and BPS Analysis by End Use, 2025 and 2035
  • Figure 4: USA Market YoY Growth Comparison by End Use, 2025 to 2035
  • Figure 5: USA Market Attractiveness Analysis by End Use
  • Figure 6: USA Market Value Share and BPS Analysis by Test Type, 2025 and 2035
  • Figure 7: USA Market YoY Growth Comparison by Test Type, 2025 to 2035
  • Figure 8: USA Market Attractiveness Analysis by Test Type
  • Figure 9: USA Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 10: USA Market YoY Growth Comparison by Region, 2025 to 2035
  • Figure 11: USA Market Attractiveness Analysis by Region
  • Figure 12: USA Market Incremental Dollar Opportunity, 2025 to 2035
  • Figure 13: USA Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 14: USA Market Value Share and BPS Analysis by End Use, 2025 and 2035
  • Figure 15: USA Market YoY Growth Comparison by End Use, 2025 to 2035
  • Figure 16: USA Market Attractiveness Analysis by End Use
  • Figure 17: USA Market Value Share and BPS Analysis by Test Type, 2025 and 2035
  • Figure 18: USA Market YoY Growth Comparison by Test Type, 2025 to 2035
  • Figure 19: USA Market Attractiveness Analysis by Test Type
  • Figure 20: USA Market - Tier Structure Analysis
  • Figure 21: USA Market - Company Share Analysis

Demand for Hepatitis E Diagnostic Tests in USA